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Edited by Gianni CesareniAbstract We observed that interaction of secondary necrotic
(sn) cells with human serum or plasma leads to loss of DNA
staining. The decrease turned out to be a result of nucleosome re-
lease and was speciﬁc for apoptotic cells as necrotic cells did not
show this phenomenon. We named this activity in plasma nucle-
osome releasing factor (NRF). NRF activity was completely
inhibited by trypsin inhibitors suggesting that a serine protease
is involved. Upon testing a number of plasma candidate serine
proteases we found that plasmin did have NRF activity. How-
ever, plasminogen-deﬁcient plasma still had NRF activity indi-
cating that NRF is not plasmin. We conclude that a yet
unidentiﬁed plasma serine protease is involved in removal of
nucleosomes from sn cells.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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releasing factor1. Introduction
Tissue homeostasis in multicellular organisms requires the
production of new cells whereas senescent or potentially haz-
ardous cells have to be removed. Such unwanted cells undergo
a process of programmed cell death, or apoptosis, which
results in prompt recognition and removal in order to prevent
release of toxic or potentially autoantigenic intracellular con-
stituents. The expression of phosphatidylserine on the outer
phospholipid-bilayer initiates recognition of the early apopto-
tic cell by professional and amateur phagocytes bearing scav-Abbreviations: AU, arbitrary unit; CM, culture medium; CM, culture
medium without FCS; MFI, median ﬂuorescence intensity; NRF,
nucleosome releasing factor; PI, propidium iodide; PMSF, phen-
ylmethylsulfonylﬂuoride; SBTI, soybean trypsin inhibitor; tPA, tissue-
type plasminogen activator; uPA, urokinase-type plasminogen
activator; sn, secondary necrotic
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doi:10.1016/j.febslet.2007.10.037enger receptors [1,2]. Binding of serum proteins, such as b2-
glycoprotein-I and serum amyloid P component (SAP), may
promote phagocytosis of early apoptotic cells [3–5].
Ongoing apoptosis in the absence of phagocytosis will
inevitably result in secondary necrotic (sn) cells. Sn cells bind
serum proteins such as immunoglobulins, SAP, C-reactive
protein (CRP), mannan binding lectin and complement, which
promote rapid clearance of sn cells by phagocytes [6–10]. The
importance of opsonization of sn cells is further supported by
the observation that complement binding is a rather late event
during apoptosis as compared to early complement binding to
necrotic cells [11]. Likewise, IgM and complement deﬁciencies
have been associated with defective clearance of apoptotic cells
[12,13]. Exposure to intracellular contents due to secondary
necrosis may trigger autoimmunity or even autoimmune dis-
ease [14,15].
A recent study has shown that the corporate action of plas-
min and DNAse results in nucleosome release from necrotic
cells [16]. Necrotic cells bind plasminogen and urokinase-type
plasminogen activator (uPA) leading to plasmin generation.
Plasmin degrades histones and facilitates the breakdown of
chromatin by serum DNAse-I in necrotic cells and the release
of chromatin may attribute to the development of systemic
autoimmunity. Such a mechanism may also contribute to re-
lease of nucleosomes from sn cells, as apoptotic cell blebs are
sites of enhanced coagulation [17,18].
We observed that incubation of sn cells with serum or plas-
ma decreased nuclear staining and that this phenomenon was
absent in necrotic cells. We demonstrate that the decrease in
nuclear staining is associated with nucleosome release and we
made an eﬀort to characterize this nucleosome releasing activ-
ity in plasma.2. Material and methods
2.1. Reagents
Monoclonal antibodies speciﬁc for nucleosomes (CLB.ANA-58),
histone H3 (CLB.ANA-60), CD95 (CLB. CD95-18), CD3 (CLB.T3/
4E), CD28 (CLB.CD28.1), plasmin and its proenzyme plasminogen
(CLB/AP-1), aﬃnity puriﬁed polyclonal antibodies speciﬁc for plasmin
and plasminogen, puriﬁed a2-antiplasmin, antithrombin and C1-inhib-
itor were produced in our laboratory [19]. Recombinant IL-2 was a
kind gift of Dr. A. Creasey, Chiron, Emeryville, CA, USA. Annexin
V-APC was obtained from BD Pharmingen (Erembodegem, Belgium).blished by Elsevier B.V. All rights reserved.
S. Zeerleder et al. / FEBS Letters 581 (2007) 5382–5388 5383Etoposide, soybean trypsin inhibitor (SBTI), benzamidin, phenyl-
methylsulfonylﬂuoride (PMSF), RNase, propidium iodide (PI), tis-
sue-type plasminogen activator (tPA), plasminogen (plg) and plasmin
(pl) were purchased by Sigma (St. Louis, MO). Urokinase-type plas-
minogen activator (uPA) was from technoclone TC (Vienna, Austria).
Complete/EDTA-free, a broad-spectrum protease inhibitor was ob-
tained from Roche (Mannheim, Germany) and aprotinin (Trasylol)
was obtained from Bayer (Mijdrecht, The Netherlands). e-Amino ca-
proic acid was obtained from Calbiochem (San Diego, CA). CnBr-Se-
pharose was from Pharmacia Biochem (Uppsala, Sweden).2.2. Cell culture, apoptosis and necrosis induction
Jurkat cells were maintained in culture medium (IMDM supple-
mented with 5% foetal calf serum (FCS), penicillin, streptomycin and
50 lM b-mercapto-ethanol) further referred to as culture medium
(CM). Peripheral blood mononuclear cells (PBMC’s) were isolated di-
rectly from aphaeresis by separation with an Elutra (Gambro, Lake-
wood, USA) and were cultured at 20000 cells/ml for 6 days in CM
(IMDM supplemented with 5% heat-inactivated human pool serum
(HPS), penicillin, streptomycin, 50 lM b-mercapto-ethanol, anti-CD3
(0.1 lg/ml), anti-CD28 (1 lg/ml) and 100 U/ml recombinant IL-2)
[20]. Cells were washed twice in CMwithout FCS or HPS (CM) before
apoptosis or necrosis induction to prevent the interaction of FCS or
HPS proteins with apoptotic cells. To obtain sn (late apoptotic) cells,
Jurkat cells or PBMC’s were incubated with CM containing 200 lM
etoposide or anti-CD95 (5 lg/ml) for 16–20 h. After apoptosis induc-
tion with etoposide or anti-CD95 only 25% of the unstimulated
PBMC’s were sn after 24 h. In contrast, treatment with etoposide or
anti-CD95 of stimulated PBMC’s resulted in 40% and 30% sn cells after
24 h. Therefore, stimulated PBMC’s have been used for these experi-
ments. Necrotic Jurkat cells were obtained after incubation with
CM containing 0.3% H2O2 for 60 min at 60 C. In preliminary exper-
iments, the behaviour of cells made necrotic by treatment with 70% eth-
anol or heating at 56 C for 30 min was tested as well. Since the results
with ethanol, heat shock and H2O2 were comparable, H2O2 was used to
induce necrosis in these experiments. Prior to FACS analysis cells were
treated with RNase for 30 min at 37 C at a ﬁnal concentration of
40 lg/ml. To stop the reaction cells were put on ice until further use.2.3. Recalciﬁed plasma
In preliminary experiments we used serum as a source of nucleosome
releasing factor (NRF). It turns out that most sera contain abundant
numbers of particles that show up as events in the scatter analysis
which do not stain with PI or Annexin V. Moreover, freeze–thawing
of serum turned out to generate new particles. High speed centrifuga-
tion or ﬁltration will lead to strong reduction of these particles in ser-
um. Since these issues can easily circumvented by using plasma and
recalciﬁed plasma turned out to remove nucleosomes as eﬃciently as
serum we used recalciﬁed plasma as a source of NRF. In the text, recal-
ciﬁed plasma is denoted as plasma.
Blood was collected from healthy donors in siliconized tubes con-
taining sodium citrate at a ﬁnal concentration of 10 mM. The vials
were immediately centrifuged two times for 10 min at 1300 · g at
4 C to achieve platelet poor plasma. Plasma was transferred to a glass
vial, recalciﬁed with CaCl2 at a ﬁnal concentration of 10 mM and incu-
bated for 15 min at 37 C, followed by incubation for 30 min at 4 C
until a retracted clot had formed. The clot was removed and the plas-
ma was stored at 20 C until use.
2.4. Detection of apoptotic and necrotic cells
Apoptotic and necrotic cells were washed in FACS buﬀer (10 mM
HEPES, pH 7.2, containing 150 mM NaCl, 5 mM KCl, 2 mM CaCl2,
2 mMMgCl2, further referred to as FB) and stained with 1:200 Annex-
in V-APC in ice-cold FB for 10 min. Then the cells were washed in
ice-cold FB and 500 ng/ml PI was added. Finally, a cell sample was
spotted on an object glass, wet mounted and immediately evaluated
under a ﬂuorescence microscope. Annexin V+ and PI+ Jurkat cells with
fragmented or condensed nuclei were scored as sn cells and Annexin
V+/PI++ cells without nuclear changes as necrotic cells.
The median ﬂuorescence intensity (MFI) of PI binding to Annexin
V/PI double-stained cells (at least 10000 events/sample) was quantiﬁed
with BD LSR II ﬂowcytometer (Becton Dickinson, Mountain View,
CA) using Facs Diva software (Becton Dickinson, Mountain View,
CA).2.5. Nucleosome release from apoptotic cells
Apoptotic and necrotic cells were washed twice in CM and re-sus-
pended in CM. The cells were transferred to a 96-well round bottom
plate (1–2 · 105 cells/well), centrifuged at 1300 · g and the supernatant
was removed. The cell pellet was re-suspended in dilutions of plasma in
CM (100–200 ll/well) and incubated for 30 min at 37 C. The super-
natant was collected and stored at 20 C until further use. Nucleo-
some levels were determined with an ELISA as previously described
with some modiﬁcations [21]. In brief, ELISA plates were coated with
monoclonal anti-histone H3 antibody (CLB/ANA-60) and the samples
were added and incubated for 1 h at room temperature. After washing,
biotin-labelled F(ab 0)2 fragments of monoclonal antinucleosome anti-
body (CLB/ANA-58) were added and incubated for another hour at
room temperature. Binding of biotin-labelled antibodies was detected
with streptavidin-horse radish peroxidase (HRP) using tetramethyl-
benzidine (TMB) as a substrate. The reaction was stopped with 2 M
H2SO4 and the absorbance was measured at 450 nm. Serial dilutions
of a culture supernatant of approximately 1 · 106/ml Jurkat cells, cul-
tured for a week with etoposide to obtain 100% dead cells were used as
a standard. The levels of nucleosomes were expressed in arbitrary units
(AU). One AU is the amount of nucleosomes released by approxi-
mately 100 dead Jurkat cells. The detection limit of the ELISA was
2 AU/ml.2.6. The eﬀect of protease inhibitors on PI staining and nucleosome
release
Complete/EDTA-free working-dilution (1 tablet in 10 ml water,
prepared according to manufacturer prescriptions), EDTA, aprotinin,
SBTI, PMSF, benzamidin, e-amino-caproic acid, C1-inhibitor, anti-
thrombin and a2-antiplasmin were diluted in CM
. Ten percent plas-
ma was pre-incubated for 30 min at 37 C with the protease
inhibitors. Then 2 · 105 secondary necrotic Jurkat cells were incubated
with 100 ll of the treated plasma for 60 min at 37 C. Finally, the cells
were washed with FB, stained with PI and analyzed with ﬂowcytome-
try. Untreated plasma was used as a positive control. The apoptotic
cell supernatant was collected to measure the nucleosome concentra-
tion.
2.6.1. The eﬀect of plasmin and plasminogen on PI staining. Plasmin
and its pro-enzyme plasminogen were diluted in diﬀerent concentra-
tions in CM. In another set of experiments plasminogen at a concen-
tration of 150 nM was incubated with increasing concentrations of
either tPA or uPA for 15 min at 37 C. As controls, tPA or uPA at
increasing concentrations were incubated with buﬀer only for 15 min
at 37 C. Next, 100 ll of the protease dilution was added to 2 · 105 sec-
ondary necrotic Jurkat cells and the cells were incubated for 30 min at
37 C. Finally, cells were washed with FB, stained with PI and ana-
lyzed with ﬂowcytometry as described above.2.7. Plasminogen depletion of plasma
Monoclonal anti-plasminogen antibody (15 mg, recognising both
plasminogen and plasmin) was coupled to 0.75 g CNBr-Sepharose,
according to instructions of the manufacturer. The aﬃnity-column
was equilibrated with 30 ml 20 mM sodium citrate (pH 6.0) contain-
ing 1 M NaCl and 0.02% Tween20. NaCl was added to plasma to a
ﬁnal concentration of 1 M. Five milliliters of plasma containing 1 M
NaCl was applied to the column. The ﬂow-through was dialyzed
against 20 mM phosphate buﬀer containing 140 mM NaCl and
0.02% Tween20 overnight (volume after dialysis 10.5 ml). The plas-
minogen level after depletion and dialysis was determined with ELI-
SA. In brief, an aﬃnity-puriﬁed rabbit polyclonal anti-plasminogen
was coated on an ELISA plate. A titration of plasma was used as
a standard assuming 1 ml of plasma to contain 100 U of plasmino-
gen. Standard and samples were incubated for 1 h at room tempera-
ture. After washing, biotinylated monoclonal anti-plasminogen
antibody was added and incubated for another hour at room temper-
ature. Binding of biotin-labelled antibodies was detected with strepta-
vidin-HRP using TMB as a substrate. The reaction was stopped with
2 M H2SO4 and the absorbance was measured at 450 nm. In order to
test the nucleosome releasing activity of plasminogen-depleted plasma
either plasma or plasminogen-depleted plasma was incubated in dif-
ferent concentrations with sn cells for 30 min at 37 C. Thereafter,
cells were washed and stained with PI and analyzed as described
above.
Fig. 1. Plasma induces a decrease of propidium iodide (PI) staining in secondary necrotic (sn) cells. Living (top), sn (middle) and necrotic Jurkat cells
(bottom) were incubated with either buﬀer (left) or 50% plasma (right) (A). Living cells contained 10% sn cells as indicated by a population of PI and
Annexin V positive cells (A, top). Secondary necrotic (open circles) and necrotic Jurkat cells (closed circles) were incubated with increasing
concentrations of plasma (B). Since the PI staining without plasma in necrotic cells (median ﬂuorescence intensity 5167 ± 497) was stronger as
compared to apoptotic cells without plasma (2617 ± 41), the data were normalized taken apoptotic or necrotic cells incubated with buﬀer only as
100%. Results are indicated as means ± S.E. of the mean (n = 3).
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3.1. The eﬀect of plasma on the PI staining of sn cells
Annexin V and PI double-stained secondary necrotic Jurkat
cells after apoptosis induction with etoposide showed a MFI of
2617 ± 41 for PI in the absence of plasma whereas incubation
for 30 min with 50% plasma reduced PI staining by 79% to558 ± 26 (Fig. 1A). No such eﬀect of 50% plasma on PI stain-
ing could be seen in living and necrotic cells, respectively. A
similar eﬀect was observed after apoptosis induction with
anti-CD95: the PI staining in late apoptotic Jurkat cells
decreased from a MFI of 2106 ± 38 without plasma to
233 ± 11 with 20% plasma. The same results were obtained
when other cell lines, such as CHO-K1 and SKW6.4 cells, were
Fig. 2. Plasma induces a decrease in propidium iodide (PI) staining in secondary necrotic (sn) peripheral blood mononuclear cells. After 6 days
culturing of primary lymphocytes stimulated with anti-CD3, anti-CD28 and IL-2, apoptosis was induced with 200 lM etoposide. Secondary necrotic
peripheral blood mononuclear cells (PBMC’s) were then incubated with plasma. PI staining of sn (double positive for Annexin V and PI) cells is
shown after incubation with n., 5% and 20% plasma, respectively (A–C).
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Fig. 3. Plasma induces nucleosome release in secondary necrotic cells.
Secondary necrotic Jurkat cells were incubated with diﬀerent concen-
trations of plasma. Cells were centrifuged and the pellet was stained
with propidium iodide (closed circles). The release of nucleosomes in
the supernatant of the cells was detected with ELISA (open circles).
Results are indicated as means ± S.E. of the mean. AU/ml: arbitrary
units per ml, MFI: median ﬂuorescence intensity.
Table 1
The eﬀect of protease inhibitors on the plasma-induced decrease of
nuclear staining of secondary necrotic cells in the presence of 10%
plasma
Protease inhibitora Concentration
(range)b
Eﬀect on propidium
iodide staining
Complete/EDTA-freec 1:160* Inhibition
Aprotinin 4 KIU/ml*,d Inhibition
Benzamidine 100 mM* Inhibition
e-Amino-caproic-acid 100 mM None
EDTA 20 mM None
PMSF 2.5 mM* Inhibition
SBTI 36 lM* Inhibition
C1-inhibitor 76 lM None
Antithrombin 1,7 lM None
a2-antiplasmin 1,6 lM None
aPMSF, phenylmethylsulfonylﬂuoride, SBTI, soy bean trypsin inhibi-
tor.
bHighest concentration that was tested, or *the lowest concentration
that showed inhibition.
cWorking solution (see Section 2).
dKIU, Kallikrein-inhibiting unit.
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Fig. 4. Aprotinin and soybean trypsin inhibitor inhibit plasma-
mediated nucleosome release in secondary necrotic cells. Secondary
necrotic Jurkat cells were incubated with plasma (10%) containing
diﬀerent concentrations of aprotinin (A) or soybean trypsin inhibitor
(SBTI, B). Cells were centrifuged and the pellet was stained with
propidium iodide (PI) (closed circles). The release of nucleosomes in
the supernatant of the cells was detected with ELISA (open circles).
Results are indicated as means ± S.E. of the mean (n = 3). The median
ﬂuorescence intensity of PI staining and the nucleosome concentration
in the supernatant of sn cells incubated with 10% plasma without
inhibitors were 1308 ± 4 and 10649 ± 1773 AU/ml, respectively. AU/
ml: arbitrary units per ml, MFI: median ﬂuorescence intensity, KIU/
ml: Kallikrein inhibiting units per ml.
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might seriously damage internal cellular components which
may act as cofactor for the eﬀect observed upon incubation
of sn cells with plasma. However, similar results were obtained
when ethanol or heat shock was used to induce necrosis (data
not shown). The eﬀect of plasma on sn cells was not restricted
to cell lines but could be observed in sn PBMC’s after apopto-
sis induction as well (Fig. 2).
3.1.1. Measurement of nucleosomes in supernatant of sn cells
after plasma incubation. The loss of PI staining after plasma
incubation could be the result of DNA release or plasma might10 100 1000
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Fig. 5. Plasmin removes nucleosomes from secondary necrotic (sn)
cells. Secondary necrotic Jurkat cells were incubated with dilutions of
either puriﬁed plasmin (open triangles) or plasminogen (closed
triangles) and stained with propidium iodide (PI) (A). Secondary
necrotic cells incubated with dilutions of uPA alone (closed squares) or
dilutions of uPA preincubated with 150 nM plasminogen (open
squares) were stained with PI (B). Sn cells incubated with dilutions
of tPA alone (closed circles) or with dilutions of tPA preincubated with
150 nM plasminogen (open circle) were stained with PI. Results are
indicated as means ± S.E. of the mean (n = 3). MFI: median ﬂuores-
cence intensity.
0 1 10 100
plasma (%)
Fig. 6. Plasminogen-depleted plasma maintains its nucleosome releas-
ing capacity. The eﬀect of plasminogen depletion on the median
ﬂuorescence intensity (MFI) of propidium iodide (PI) staining of sn
cells. Sn cells were incubated with several dilutions of plasma (open
circles) or plasminogen-depleted plasma (closed circles). The dilution
of plasminogen-depleted plasma were corrected for dilutions achieved
during plasminogen depletion (dilutionfactor 2.1) and are indicated in
% of plasma. Results are indicated as means ± S.E. of the mean
(n = 3).interfere with PI staining. Therefore, we analyzed the release of
nucleosomes from sn cells after incubation with plasma. The
supernatant of sn cells contained 24 ± 2 AU/ml nucleosomes
when incubated with CM alone, whereas a dose-dependent
increase in nucleosome levels was observed up to
10764 ± 724 AU/ml in the presence of 20% plasma (Fig. 3).
The increased nucleosome release coincided with a reduction
of the PI staining of the sn cells from approximately
5195 ± 195 to 1186 ± 2 (Fig. 3). Notably, nucleosomes in nor-
mal donor plasma were below detection level (not shown). In
another approach using sn cells with 3H-labelled DNA a
dose-dependent release of 3H-labelled DNA from the cells into
the supernatant upon plasma incubation was observed (data
not shown).
3.2. Mechanism of nucleosome release from apoptotic cells
The release of nucleosomes in the apoptotic cell supernatant
and the concomitant decrease in PI staining was absent when
apoptotic cells were incubated with plasma at 4 C or when
plasma was heated for 60 min at 56 C (not shown). This sug-
gested that an enzymatic process may be involved and we
decided to denote this activity as nucleosome releasing factor
(further referred to as NRF). To resolve the nature of NRF
activity we tested a series of protease inhibitors (Table 1). Pre-
incubation of plasma with Complete/EDTA-free abrogated
NRF activity while no inhibition of the NRF activity was ob-
served after preincubation of plasma with EDTA. Phen-
ylmethylsulfonylﬂuoride (PMSF) abrogated NRF activity at
a concentration of 2.5 mM (Table 1). Moreover, preincubation
of plasma with aprotinin and soybean trypsin inhibitor (SBTI)
showed a dose-dependent inhibition of NRF activity (Fig. 4).
Notably, preincubation of sn cells with the above mentioned
protease inhibitors followed by a wash prior to the addition
of plasma had no eﬀect on NRF activity.
It has been shown that the plasminogen system is involved in
the release of nucleosomes from necrotic cells [16] and we ob-
served that the NRF activity is inhibited by aprotinin and
SBTI suggesting that the NRF activity might be due to plas-
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ine proteases involved in the plasminogen system. Plasmin dis-
played a dose-dependent NRF activity and plasminogen with
simultaneous addition of either tPA or uPA was active as well
(Fig. 5). In contrast, no NRF activity was observed when puri-
ﬁed plasminogen, uPA or tPA were added separately.
3.3. The eﬀect of plasminogen depletion on NRF activity
As plasmin seemed to be involved in the release of nucleo-
somes from sn cells, we depleted plasminogen from plasma
with aﬃnity chromatography. Plasma was applied once to
the column thereby reducing the total plasminogen content
from 500 U to a total 20 U in the ﬂow through. Interestingly,
the NRF activities of plasminogen-depleted plasma and nor-
mal plasma were equal (Fig. 6).4. Discussion
Surrounding phagocytes rapidly clear early apoptotic cells
and thus prevent exposure to apoptotic cell cytoplasmic and
nuclear contents. However, little is known about the process-
ing of sn cells. We studied the eﬀect of normal human plasma
on secondary necrotic Jurkat cells and PBMC’s under culture
conditions and in the absence of phagocytes. A strong release
of nucleosomes from sn cells coincided with a decrease in nu-
clear staining with PI. The eﬀect of plasma on nuclear staining
was observed at 37 C, but was absent at 4 C and in heated
plasma, suggesting that an enzymatic process was involved.
The NRF activity was speciﬁc for sn cells as no eﬀect on nucle-
osome release was observed in necrotic cells, thus processing of
DNA by an apoptotic cell endonuclease seemed to be a prere-
quisite for nucleosome release.
Plasmin was reported to be involved in the degradation of
histones in vitro, which could possibly promote the release of
nucleosomes from sn cells [16,22]. Indeed preincubation of sn
cells with a broad-spectrum protease inhibitor (Complete/
EDTA-free), with aprotinin, PMSF or with SBTI inhibited
NRF activity of plasma. In contrast, EDTA, e-amino-caproic
acid and the naturally occurring protease inhibitors C1-inhib-
itor, a2-antiplasmin and antithrombin were inactive. Both,
aprotinin and SBTI are potent inhibitors of plasmin support-
ing the candidacy of plasmin. Indeed plasmin has NRF activ-
ity. Plasmin-free plasminogen has no NRF activity unless it
was simultaneously administered with a plasminogen activa-
tor, either uPA or tPA, showing that the apoptotic cell has
no intrinsic plasminogen-activating properties.
Notwithstanding the NRF activity of plasmin, our data
show that NRF is not plasmin. NRF activity was unaﬀected
in plasmin and plasminogen-depleted plasma, in plasma pre-
treated with e-amino-caproic acid or a2-antiplasmin enriched
plasma, indicating another protease than plasmin to exhibit
NRF in plasma. It has been shown that necrotic cells lose
nucleosomes in the presence of DNAse-I and either plasmin
or C1q [16,23]. Our observation that the release of nucleo-
somes from sn cells was unaﬀected in the presence of EDTA
argues against a role for calcium-dependent DNAses, like
DNAse-I, in the removal of nucleosomes from sn cells.
Previous studies have shown that sn cells bind various com-
plement activating proteins such as SAP, CRP, MBL, immu-
noglobulins and C1q and binding of these proteins to sn
cells may promote complement activation [4–9]. Moreover,loss of membrane-bound inhibitors of complement activation
in the apoptotic process may facilitate apoptotic cell lysis by
complement [24,25]. EDTA abrogates complement activation
by sn cells and since no inhibitory eﬀect of EDTA on nucleo-
some release was observed, it is unlikely that complement acti-
vating proteins or complement exert substantial NRF activity.
The physiological relevance of a NRF is at present un-
known. Nucleosomes were reported to bind to glycosamino-
glycans, such as heparan sulfate [26]. Therefore, nucleosomes
released from apoptotic cells might be scavenged by binding
to heparan sulfate exposed on surrounding cells. Eﬃcient re-
moval of apoptotic cells is important since prolonged exposure
of the immune system to autoantigens exposed on the surface
of apoptotic cells and blebs may result in the development of
autoantibodies against nucleosomes [14]. Nucleosomes re-
leased into circulation are rapidly cleared by hepatocytes
[27]. However, only little is known on how nucleosomes escape
from apoptotic cells. We now demonstrate plasma to contain a
protease which removes nucleosomes from sn cells. We
hypothesize that the removal of nucleosomes from sn cells
by plasma may represent a constitutive part of a disposal pro-
gram for early apoptotic cells, which were not properly cleared
(e.g. due to excessive nucleosome release, due to decreased
clearance capacity or a combination of both) and became sn.
A decreased capacity of plasma to remove nucleosomes from
sn cells may lead to autoantibody formation to nucleosomes.
Indeed, we observed decreased NRF activity in plasma of
SLE patients, suggesting that processing of nucleosomes from
sn cells may be aﬀected (B. Zwart et al., unpublished observa-
tion).
Our results indicate that in vitro studies with apoptotic cells
should be interpreted with care. In the presence of unheated
plasma sn cells lose nucleosomes and thus staining with
DNA-binding dyes, such as PI, is lost. Under these conditions
Annexin V+ and PI staining cells, which are designated early
apoptotic cells, may actually represent sn cells. This study may
oﬀer an explanation for the infrequent ﬁnding of sn cells
in vivo, such as in histology sections. When cell leakage occurs,
nucleosomes are removed from sn cells. Therefore, staining of
sn cells with DNA binding dyes such as hematoxylin may be
impaired.5. Conclusion
We conclude that a yet unidentiﬁed plasma protease is
instrumental in the release of nucleosomes from sn cells. The
protease that is responsible for the release of nucleosomes from
sn cells as well as the physiological relevance of this NRF re-
mains to be identiﬁed.
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